SARA KHAVER: Open Payments
NPI 1396300158 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$973 in 13 payments from 9 companies in 2025. Trend: 2023 $198 · 2024 $376 · 2025 $973
Travel & lodging: $657Food & beverage: $317
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 4 | $684 |
| Biogen, Inc. | 1 | $107 |
| ABBVIE INC. | 2 | $45 |
| AstraZeneca Pharmaceuticals LP | 1 | $34 |
| HARMONY BIOSCIENCES LLC | 1 | $25 |
| Novo Nordisk Inc | 1 | $21 |
| Amgen Inc. | 1 | $21 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $19 |
| Inspire Medical Systems, Inc. | 1 | $18 |
Products named: Varithena Administration Pack, ZURZUVAE, QULIPTA, AIRSUPRA, WAKIX, Ozempic, KRYSTEXXA, JARDIANCE.
Industry payments across MD — which companies pay providers there.
